查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1628144

电生理学市场机会、成长驱动因素、产业趋势分析与预测 2025 - 2034

Electrophysiology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 132 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球电生理学市场价值为 69 亿美元，预计 2025 年至 2034 年复合年增长率为 10.4%。此领域使用心电图 (ECG)、肌电图 (EMG) 和膜片钳记录等各种技术来测量和分析电讯号。

心房颤动（AF）等心臟疾病的盛行率不断上升是市场成长的主要动力。随着全球人口老化，对电生理学先进诊断和治疗方案的需求不断增长。医疗保健提供者正致力于更好地管理心臟问题，这促进了电生理技术的采用。

技术创新也大大推动了市场扩张。电生理学设备变得越来越先进，提高了治疗效果和安全性。微创导管消融手术越来越受欢迎，因为这些技术可以为心律不整和其他心臟病患者提供更好的治疗效果。

市场范围
开始年份 2024年
预测年份 2025-2034
起始值 69 亿美元
预测值 188 亿美元
复合年增长率 10.4%

市场依产品分为电生理学 (EP) 消融导管、诊断导管和 EP 实验室设备。 EP 消融导管占最大份额，到 2024 年将占市场的 49.1%。高解析度测绘系统等现代技术提高了消融的精度，针对异常电讯号，对周围健康组织的伤害最小。

不同类型的消融导管，例如使用射频 (RF)、冷冻消融和雷射能量的消融导管，根据特定病例和患者需求为临床医生提供了一系列选择。特别是冷冻消融术可以最大程度地减少热损伤，使其成为某些手术的首选。现在许多导管都具有即时监控功能，确保消融过程安全有效。

依适应症，市场分为心房颤动、室性心搏过速、心房扑动等病症。心房颤动是最大的细分市场，由于全球范围内心房颤动发病率的上升，预计未来几年将显着增长。

对于最终用户，电生理学市场服务于医院、导管实验室、门诊手术中心和其他医疗机构。尤其是医院在这一领域占据主导地位，拥有提供先进诊断和治疗选择的专业部门。这些医院通常拥有专门的电生理学团队和最先进的设备，以确保高品质的护理。

在完善的医疗保健体系、监管支援和先进的医疗设施的支持下，美国市场预计将大幅成长。该国的基础设施和 FDA 的新技术审批流程创造了有利于电生理学领域创新的环境，确保了尖端设备和技术的持续开发和采用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心房颤动的盛行率不断增加
      • 电生理设备的技术进步
      • 对电生理导管消融的偏好日益增加
    • 产业陷阱与挑战
      • 电生理设备投资高
      • 新兴国家缺乏熟练的专业人员
  • 成长潜力分析
  • 监管环境
  • 技术景观
    • 核心技术
    • 邻近技术
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2034 年

  • 主要趋势
  • EP消融导管
    • 射频 (RF)
    • 冷冻消融
    • 雷射
    • 其他 EP 消融导管
  • EP诊断导管
    • 传统的
    • 先进的
    • 超音波
  • EP实验室设备
    • 测绘系统
    • 录音系统
    • 其他EP实验室设备

第 6 章：市场估计与预测：按指标划分，2021 - 2034 年

  • 主要趋势
  • 心房震颤
  • 室性心搏过速
  • 房性心搏过速
  • 心房扑动
  • WOLFF-帕金森-怀特 (WPW) 综合征
  • 房室结折返性心搏过速

第 7 章：市场估计与预测：按最终用途，2021 - 2034 年

  • 主要趋势
  • 医院
  • 导管插入/电生理实验室
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 俄罗斯
    • 乌克兰
    • 波兰
    • 瑞士
    • 比利时
    • 希腊
    • 捷克共和国
    • 荷兰
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 马来西亚
    • 印尼
    • 泰国
    • 新加坡
    • 台湾
    • 菲律宾
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 科威特
    • 阿联酋

第 9 章：公司简介

  • Abbott Laboratories
  • APN Health
  • Atricure
  • Biotronik
  • Boston Scientific Corporation
  • CardioFocus
  • GE Healthcare Technologies
  • Japan Lifeline
  • Johnson & Johnson
  • Koninklijke Philips
  • Medtronic
  • Microport Scientific Corporation
  • Merit Medical Systems
  • Siemens Healthineers
  • Stereotaxis
简介目录
Product Code: 2968

The Global Electrophysiology Market was valued at USD 6.9 billion in 2024 and is expected to grow at a CAGR of 10.4% from 2025 to 2034. Electrophysiology studies the electrical properties of biological tissues and cells, particularly focusing on nerve and muscle cells. This field uses various techniques such as electrocardiography (ECG), electromyography (EMG), and patch-clamp recordings to measure and analyze electrical signals.

The increasing prevalence of heart conditions like atrial fibrillation (AF) is a major driver of market growth. As the global population ages, the demand for advanced diagnostic and treatment options in electrophysiology is growing. Healthcare providers are focusing on better management of cardiac issues, which is boosting the adoption of electrophysiological techniques.

Technological innovations are also significantly fueling market expansion. Electrophysiology devices are becoming more advanced, improving treatment efficacy and safety. The popularity of catheter ablation procedures, which are minimally invasive, is rising as these techniques offer better outcomes for patients with arrhythmias and other heart conditions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$6.9 Billion
Forecast Value$18.8 Billion
CAGR10.4%

The market is segmented by product into electrophysiology (EP) ablation catheters, diagnostic catheters, and EP laboratory devices. EP ablation catheters accounted for the largest share, making up 49.1% of the market in 2024. These catheters are designed to deliver energy directly to the tissue causing irregular heartbeats. Modern technologies like high-resolution mapping systems improve the precision of ablation, targeting the abnormal electrical signals with minimal harm to surrounding healthy tissue.

Different types of ablation catheters, such as those using radiofrequency (RF), cryoablation, and laser energy, offer clinicians a range of options depending on the specific case and patient needs. Cryoablation, in particular, minimizes thermal damage, making it a preferred choice in some procedures. Many of these catheters now feature real-time monitoring capabilities, ensuring that the ablation process is both safe and effective.

By indication, the market is divided into atrial fibrillation, ventricular tachycardia, atrial flutter, and other conditions. The atrial fibrillation segment is the largest and is expected to see significant growth in the coming years due to the rising incidence of the condition worldwide.

Regarding end users, the electrophysiology market serves hospitals, catheterization laboratories, ambulatory surgery centers, and other healthcare facilities. Hospitals, in particular, dominate this segment, with specialized departments that offer advanced diagnostics and treatment options. These hospitals often have dedicated electrophysiology teams and state-of-the-art equipment that ensures high-quality care.

The U.S. market is expected to see substantial growth, supported by a well-established healthcare system, regulatory support, and advanced medical facilities. The country's infrastructure and the FDA's approval processes for new technologies create an environment conducive to innovation in the electrophysiology space, ensuring the continued development and adoption of cutting-edge devices and techniques.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of atrial fibrillation
      • 3.2.1.2 Technological advancements in electrophysiology devices
      • 3.2.1.3 Increasing preference for electrophysiology catheter ablation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High investment for electrophysiology devices
      • 3.2.2.2 Dearth of skilled professionals in emerging nations
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 EP ablation catheters
    • 5.2.1 Radiofrequency (RF)
    • 5.2.2 Cryoablation
    • 5.2.3 Laser
    • 5.2.4 Other EP ablation catheters
  • 5.3 EP diagnostic catheters
    • 5.3.1 Conventional
    • 5.3.2 Advanced
    • 5.3.3 Ultrasound
  • 5.4 EP laboratory devices
    • 5.4.1 Mapping systems
    • 5.4.2 Recording systems
    • 5.4.3 Other EP laboratory devices

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Atrial fibrillation
  • 6.3 Ventricular tachycardia
  • 6.4 Atrial tachycardia
  • 6.5 Atrial flutter
  • 6.6 WOLFF-Parkinson-white (WPW) syndrome
  • 6.7 Atrioventricular nodal reentry tachycardia

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Catheterization/EP laboratories
  • 7.4 Ambulatory surgery centers
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Ukraine
    • 8.3.8 Poland
    • 8.3.9 Switzerland
    • 8.3.10 Belgium
    • 8.3.11 Greece
    • 8.3.12 Czech Republic
    • 8.3.13 Netherlands
    • 8.3.14 Sweden
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Malaysia
    • 8.4.7 Indonesia
    • 8.4.8 Thailand
    • 8.4.9 Singapore
    • 8.4.10 Taiwan
    • 8.4.11 Philippines
    • 8.4.12 Vietnam
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Kuwait
    • 8.6.4 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 APN Health
  • 9.3 Atricure
  • 9.4 Biotronik
  • 9.5 Boston Scientific Corporation
  • 9.6 CardioFocus
  • 9.7 GE Healthcare Technologies
  • 9.8 Japan Lifeline
  • 9.9 Johnson & Johnson
  • 9.10 Koninklijke Philips
  • 9.11 Medtronic
  • 9.12 Microport Scientific Corporation
  • 9.13 Merit Medical Systems
  • 9.14 Siemens Healthineers
  • 9.15 Stereotaxis